A new, possibly under-utilized treatment could help keep COVID-19 hospitalizations down

AN ANTONIO - Healthcare experts are calling monoclonal antibodies an under-utilized drug that is showing promising results in the fight against COVID-19.

"They are really manmade proteins that were just like your own antibodies in your system that your immune system creates, to fight off allergens that are on bacteria, viruses, transplanted organs, those types of things," said University Health's Senior Vice President and Chief Pharmacy Officer Elliott Mandell.

Read the full article right here.


© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.